Clexane is considered as therapeutic solution that prevents and treats thrombosis that may also affects a significant percentage of Covid-19 patients with severe symptoms.

Through this MOU, (AJA Pharma), a subsidiary of Saudi Chemical Company Holding, would provide manufacturing facilities and systems that function efficiently, safely, and reliably to produce Clexane prefilled syringes and expand its services in the Saudi market. (SCCH) is keen to invest in vital sectors and value-added projects to serve and meet the community needs, contribute to local industries diversification, increase local content and drive economic development towards achieving the Kingdom of Saudi Arabia’s Vision 2030 goals.